
David Hockenbery
Site Director, Fred Hutchinson Cancer Center · University of Washington School of Medicine
Credentials: · · · ·
History
- 1988–1991
Gastroenterology


Research
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Nature · 1990 · First of 5 authors · 3,653 citations
Bcl-2 functions in an antioxidant pathway to prevent apoptosis
Cell · 1993 · First of 5 authors · 3,206 citations
BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death
Proceedings of the National Academy of Sciences of the United States of America · 1991 · First of 5 authors · 1,326 citations

George McDonald
11 papers

6 papers
- CG
5 papers
- ST
5 papers

4 papers

4 papers

3 papers

3 papers
Grants
- 2023–2027
National Heart, Lung, and Blood Institute · R01
PI · $5.8M · Fred Hutchinson Cancer Center
- 2017–2023
Delineating the Mechanisms and Clinical Utility of mtDNA Mutagenesis in Cancer
National Cancer Institute · R01
Contact PI · $402.6K · Fred Hutchinson Cancer Center
- 2017–2021
Role of FA-BRCA Pathway in Stem Cell Resistance to Acetaldehyde
National Institute on Alcohol Abuse and Alcoholism · R21
Contact PI · $466.9K · Fred Hutchinson Cancer Research Center
- 2012–2017
Metabolism, Protein and miRNA Cross-Talk in Cell Cycle and Tumor Progression
National Cancer Institute · R01
Contact PI · $1.8M · Fred Hutchinson Cancer Research Center
Clinical trials
- 2009–2012
Principal investigator · Terminated · Phase 3
Soligenix
- 2000–2002
Study chair · Completed · Phase 1, Phase 2
Fred Hutchinson Cancer Center




